[EN] NOVEL PROCESS FOR THE PREPARATION OF 1-(3-ETHOXY-4-METHOXY-PHENYL)-2-METHYLSULFONYL-ETHANAMINE<br/>[FR] NOUVEAU PROCÉDÉ DE PRÉPARATION DE 1-(3-ÉTHOXY-4-MÉTHOXY-PHÉNYL)-2-MÉTHYLSULFONYL-ÉTHANAMINE
申请人:SUN PHARMACEUTICAL IND LTD
公开号:WO2018061034A1
公开(公告)日:2018-04-05
The present invention relates to a process for the preparation of 1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethanamine, an intermediate for the preparation of apremilast via a compound of Formula (V) wherein R is (C1-C4)alkyl, (C1-C4)haloalkyl, -O(C1-C4)alkyl, or –O-benzyl, and L is a leaving group.
[EN] IMPROVED PROCESS FOR THE PREPARATION OF APREMILAST<br/>[FR] PROCÉDÉ AMÉLIORÉ POUR LA PRÉPARATION D'APRÉMILAST
申请人:DAVULURI RAMAMOHAN RAO
公开号:WO2017179065A1
公开(公告)日:2017-10-19
The present invention relates to an improved process for the preparation of Apremilast of formula (I).
本发明涉及一种改进的制备化合物Apremilast(化学式为I)的方法。
Processes for the preparation of ß-aminosulfone compounds
申请人:LEK Pharmaceuticals d.d.
公开号:EP2949645A1
公开(公告)日:2015-12-02
The present invention relates to processes for preparing β-aminosulfone compounds. The provided compounds are useful intermediates in the preparation of sulfone group containing isoindoline-based compounds, in particular apremilast.
Isoindoline derivative, pharmaceutical composition and use thereof
申请人:Kangpu Biopharmaceuticals, Ltd.
公开号:US11337964B2
公开(公告)日:2022-05-24
Disclosed are a novel isoindoline derivative, a pharmaceutical composition and use thereof. The compound of formula I, or the pharmaceutically acceptable salt, solvate, polymorph, co-crystal, stereoisomer, isotopic compound, metabolite or prodrug thereof disclosed in the invention can regulate the generation and/or activity of PDE4 and/or TNF-α so as to effectively treat cancer and inflammatory diseases.
本发明公开了一种新型异吲哚啉衍生物、一种药物组合物及其用途。本发明公开的式 I 化合物或其药学上可接受的盐、溶液剂、多晶型、共晶体、立体异构体、同位素化合物、代谢物或原药可以调节 PDE4 和/或 TNF-α 的生成和/或活性,从而有效治疗癌症和炎症性疾病。
Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease